Digital circuits operating in the sub-threshold regime consume the least energy. The strict energy constraints are desired in the applications which work at the lowest possible supply voltage. On the other hand, the c...Digital circuits operating in the sub-threshold regime consume the least energy. The strict energy constraints are desired in the applications which work at the lowest possible supply voltage. On the other hand, the conventional design flow utilizes the technology library provided by the foundry with a fixed voltage boundary, which causes problems when the supply scales down to the sub-threshold regime. In this paper, we present a design methodology to characterize the existing cell library with Liberty NCX to facilitate the standard design flow. It is demonstrated in 0.13 μm complementary metal-oxide-semiconductor （CMOS） technology with the supply voltage of 300 mV.展开更多
The successful approval of peptide-based drugs can be attributed to a collaborative effort across multiple disciplines.The integration of novel drug design and synthesis techniques,display library technology,delivery ...The successful approval of peptide-based drugs can be attributed to a collaborative effort across multiple disciplines.The integration of novel drug design and synthesis techniques,display library technology,delivery systems,bioengineering advancements,and artificial intelligence have significantly expedited the development of groundbreaking peptide-based drugs,effectively addressing the obstacles associated with their character,such as the rapid clearance and degradation,necessitating subcutaneous injection leading to increasing patient discomfort,and ultimately advancing translational research efforts.Peptides are presently employed in the management and diagnosis of a diverse array of medical conditions,such as diabetes mellitus,weight loss,oncology,and rare diseases,and are additionally garnering interest in facilitating targeted drug delivery platforms and the advancement of peptide-based vaccines.This paper provides an overview of the present market and clinical trial progress of peptide-based therapeutics,delivery platforms,and vaccines.It examines the key areas of research in peptide-based drug development through a literature analysis and emphasizes the structural modification principles of peptide-based drugs,as well as the recent advancements in screening,design,and delivery technologies.The accelerated advancement in the development of novel peptide-based therapeutics,including peptide-drug complexes,new peptide-based vaccines,and innovative peptide-based diagnostic reagents,has the potential to promote the era of precise customization of disease therapeutic schedule.展开更多
基金supported by the Important National S&T Special Project of China under Grant No.2011ZX01034-002-001-2
文摘Digital circuits operating in the sub-threshold regime consume the least energy. The strict energy constraints are desired in the applications which work at the lowest possible supply voltage. On the other hand, the conventional design flow utilizes the technology library provided by the foundry with a fixed voltage boundary, which causes problems when the supply scales down to the sub-threshold regime. In this paper, we present a design methodology to characterize the existing cell library with Liberty NCX to facilitate the standard design flow. It is demonstrated in 0.13 μm complementary metal-oxide-semiconductor （CMOS） technology with the supply voltage of 300 mV.
基金supported by the Natural Science Foundation of China(No.82073311)Science&Technology Department of Sichuan Province Individualized Drug Therapy Small Molecule Innovative Drugs Sichuan Youth Science and Technology Innovation Research Team(No.2022JDTD0025)Sichuan Traditional Chinese Medicine Administration(No.2023MS026).
文摘The successful approval of peptide-based drugs can be attributed to a collaborative effort across multiple disciplines.The integration of novel drug design and synthesis techniques,display library technology,delivery systems,bioengineering advancements,and artificial intelligence have significantly expedited the development of groundbreaking peptide-based drugs,effectively addressing the obstacles associated with their character,such as the rapid clearance and degradation,necessitating subcutaneous injection leading to increasing patient discomfort,and ultimately advancing translational research efforts.Peptides are presently employed in the management and diagnosis of a diverse array of medical conditions,such as diabetes mellitus,weight loss,oncology,and rare diseases,and are additionally garnering interest in facilitating targeted drug delivery platforms and the advancement of peptide-based vaccines.This paper provides an overview of the present market and clinical trial progress of peptide-based therapeutics,delivery platforms,and vaccines.It examines the key areas of research in peptide-based drug development through a literature analysis and emphasizes the structural modification principles of peptide-based drugs,as well as the recent advancements in screening,design,and delivery technologies.The accelerated advancement in the development of novel peptide-based therapeutics,including peptide-drug complexes,new peptide-based vaccines,and innovative peptide-based diagnostic reagents,has the potential to promote the era of precise customization of disease therapeutic schedule.
